Jong‐Mu Sun

Single-cell RNA sequencing demonstrates the molecular and cellular reprogramming of metastatic lung adenocarcinoma

Nayoung Kim, Hong Kwan Kim, Kyungjong Lee et al. · Nature Communications · 2020 · 1.3K citations · Full text

Medicine, Cancer Biology, Oncology +17

Gemcitabine and oxaliplatin with or without erlotinib in advanced biliary-tract cancer: a multicentre, open-label, randomised, phase 3 study

Se Hoon Park, Heung-Moon Chang, Jun Suk Kim et al. · The Lancet Oncology · 2011 · 483 citations

Medicine, Oncology, Pharmacology +9

Osimertinib for Patients With Non–Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Multicenter, Open-Label, Phase II Trial (KCSG-LU15-09)

Jang Ho Cho, Sung Hee Lim, Ho Jung An et al. · Journal of Clinical Oncology · 2019 · 359 citations · Full text

Medicine, Oncology, Pharmacology +17

Pembrolizumab for Patients With Refractory or Relapsed Thymic Epithelial Tumor: An Open-Label Phase II Trial

Jinhyun Cho, Hae Su Kim, Bo Mi Ku et al. · Journal of Clinical Oncology · 2018 · 343 citations · Full text

Medicine, Oncology, Pharmacotherapy +15

Multinational Randomized Phase III Trial With or Without Consolidation Chemotherapy Using Docetaxel and Cisplatin After Concurrent Chemoradiation in Inoperable Stage III Non–Small-Cell Lung Cancer: KCSG-LU05-04

Jin Seok Ahn, Yong Chan Ahn, Joo-Hang Kim et al. · Journal of Clinical Oncology · 2015 · 258 citations · Full text

Medicine, Oncology, Radiation Oncology +17